News & Updates
Filter by Specialty:
Show Multimedia Only
ICON8B OS data support a new SoC for epithelial ovarian cancer
29 Oct 2025
byAudrey Abella
In the final overall survival (OS) analysis of the phase III ICON8B trial, first-line treatment with bevacizumab in combination with a chemotherapeutic regimen comprising carboplatin Q3W and dose-dense paclitaxel QW improved survival in women with high-risk stage III-IV epithelial ovarian cancer.
ICON8B OS data support a new SoC for epithelial ovarian cancer
29 Oct 2025
What’s hot at APS & MCV 2025?
29 Oct 2025
MIMS Doctor brings you extensive coverage of the Asia Pneumonia Summit & MasterClass in Vaccinology 2025, held recently in Taipei, Taiwan. Check out the latest updates on RSV, pneumococcal disease, new vaccines, plus thought-provoking insights from respiratory experts. [READ THE FULL REPORT]







